ArTS Archivio della ricerca di Trieste

DECORTI, GIULIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.281
EU - Europa 7.684
AS - Asia 2.111
AF - Africa 74
SA - Sud America 61
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 9
Totale 25.245
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.242
PL - Polonia 2.427
IT - Italia 1.461
SE - Svezia 1.255
UA - Ucraina 943
CN - Cina 758
HK - Hong Kong 496
SG - Singapore 383
FI - Finlandia 338
DE - Germania 269
TR - Turchia 245
IE - Irlanda 219
BG - Bulgaria 216
GB - Regno Unito 153
FR - Francia 90
BE - Belgio 75
SN - Senegal 50
IN - India 48
BR - Brasile 42
CH - Svizzera 42
VN - Vietnam 38
JP - Giappone 36
CZ - Repubblica Ceca 34
NL - Olanda 32
RU - Federazione Russa 32
CA - Canada 29
KR - Corea 29
AU - Australia 23
ES - Italia 17
AE - Emirati Arabi Uniti 12
PK - Pakistan 12
AT - Austria 10
SI - Slovenia 10
GR - Grecia 9
AR - Argentina 8
CL - Cile 8
DK - Danimarca 8
EU - Europa 8
RO - Romania 8
TH - Thailandia 8
TN - Tunisia 8
EG - Egitto 7
MY - Malesia 7
NG - Nigeria 6
NO - Norvegia 6
PT - Portogallo 6
RS - Serbia 6
HU - Ungheria 5
IL - Israele 5
PH - Filippine 5
ID - Indonesia 4
MD - Moldavia 4
PR - Porto Rico 4
IR - Iran 3
JO - Giordania 3
MO - Macao, regione amministrativa speciale della Cina 3
PE - Perù 3
TW - Taiwan 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
EE - Estonia 2
IQ - Iraq 2
KW - Kuwait 2
LK - Sri Lanka 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CU - Cuba 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LS - Lesotho 1
LU - Lussemburgo 1
MN - Mongolia 1
MX - Messico 1
Totale 25.245
Salva come PNG Salva come JPEG
Città #
Warsaw 2.418
Woodbridge 2.164
Ann Arbor 1.851
Fairfield 1.848
Houston 1.334
Chandler 1.315
Ashburn 1.044
Wilmington 886
Jacksonville 849
Seattle 809
Cambridge 590
Trieste 576
Hong Kong 489
Princeton 392
Singapore 264
Beijing 228
Izmir 226
Sofia 216
Dublin 213
Boardman 149
Dearborn 131
San Diego 91
Brussels 75
Milan 68
Helsinki 59
Dakar 50
Munich 50
Des Moines 48
Falls Church 42
Hefei 42
Dong Ket 36
Bern 34
Brno 34
Bremen 32
Redwood City 32
Nanjing 31
Shanghai 31
Düsseldorf 30
Los Angeles 30
Santa Clara 30
Buffalo 28
Chicago 27
Jinan 27
Dallas 26
Phoenix 26
Washington 26
Seoul 24
Guangzhou 23
Kunming 23
Norwalk 23
Shenyang 23
Redmond 22
Rome 20
Fremont 19
Pune 19
Verona 16
Fano 15
Mestre 15
Nanchang 15
Amsterdam 14
London 14
Chengdu 13
Columbus 13
Tokyo 13
Detroit 12
Sydney 12
São Paulo 12
Taiyuan 12
Fuzhou 11
Dubai 10
Kocaeli 10
New York 10
Pignone 10
Udine 10
Vienna 10
Zhengzhou 10
Changsha 9
Edinburgh 9
Hebei 9
Toronto 9
Venice 9
Bologna 8
Paris 8
Taizhou 8
Wuhan 8
Clearwater 7
Lappeenranta 7
Tappahannock 7
Americana 6
Campo Grande 6
Genoa 6
Hangzhou 6
Islamabad 6
Menlo Park 6
Montreal 6
Tianjin 6
Ariano Irpino 5
Auburn Hills 5
Bangkok 5
Boulder 5
Totale 19.616
Salva come PNG Salva come JPEG
Nome #
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response 369
Pharmacogenetics of thiopurines 368
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children 356
Role of Oxidative Stress Mediated by Glutathione-S-transferase in Thiopurines' Toxic Effects 350
5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis 348
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 345
Genetic determinants for methotrexate response in juvenile idiopathic arthritis 343
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms 337
Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis? 322
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients 320
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease 289
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis 250
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 249
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia 244
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. 214
Novel motif of variable number of tandem repeats in TPMT promoter region and evolutionary association of variable number of tandem repeats with TPMT∗3 alleles 204
Pharmacogenetics of treatments for inflammatory bowel disease 201
Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease 197
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease 192
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease 191
Hemolytic Effects of Water-Soluble Fullerene Derivatives 181
Fate of Lymphocytes after Withdrawal of Tofacitinib Treatment 177
Opioid Resistance Associated with CYP3A4 Hyperactivity and COMT Polymorphism in an Oncological Patient 177
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches. 175
Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability 174
Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. 173
Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy 173
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives 173
Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. 172
Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. 171
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease. 170
Ergothioneine, a dietary amino acid with a high relevance for the interpretation of label-free surface enhanced Raman scattering (SERS) spectra of many biological samples 170
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 170
Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse. 169
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events 168
Personalized therapies in pediatric inflammatory and autoimmune diseases. 165
MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. 164
Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes 164
Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient 162
Selective resistance to different glucocorticoids in severe autoimmune disorders 160
Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide 159
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 159
Visualization of adriamycin uptake and internalization by receptor-mediated endocytosis in mast cells. An ultrastructural study using adriamycin-colloidal gold complexes. 158
Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK1 cells. 157
SERS of cells: What can we learn from cell lysates? 157
Rifampicin and verapamil induce the expression of P-glycoprotein in vivo in Ehrlich ascites tumor cells. 153
The cytotoxic effect of palytoxin on Caco-2 cells hinders their use for in vitro absorption studies. 153
Genetic Predictors of Glucocorticoid Response in Pediatric Patients With Inflammatory Bowel Diseases 153
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 153
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 153
Glutathione-S-Transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome 152
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? 152
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 152
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 152
TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype 151
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol 149
Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells. 147
Contribution of Glutathione-S-Transferases to the Pharmacogenetics of Azathioprine 147
Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone. 146
Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice. 146
Amelioration of 4'-Epidoxorubicin-induced cardiotoxicity by sodium cromoglycate. 144
Toxicity of Hypericum perforatum (St. John's wort) administered during pregnancy and lactation in rats 143
Effect of neomycin and other aminoglycosides on adriamycin uptake in rat peritoneal mast cells. 142
Glutathione S-Transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. 142
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. 141
Adriamycin binds to the matrix of secretory granules during mast cell exocytosis. 141
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 141
Effect of ketotifen on adriamycin toxicity: role of histamine. 140
Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. 140
Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease 139
In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome 139
Osteonecrosis of the hip after short courses of oral and inhaled steroids in a child with an increased number of glucocorticoid receptors 138
Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. 137
Anticonvulsant activity of two polyethylene glycols in mice. 137
Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence 136
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease 136
Pharmacogenomic approaches for tailored anti-leukemic therapy in children. 135
Biochemical and microscopic evidence for the internalization of drug-containing mast cell granules by macrophages and smooth muscle cells 134
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort 134
Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease. 133
Interaction of adriamycin with rat and mouse mast cells: histamine release and cellular uptake. 133
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 133
Letter: TPMT activity and age in IBD patients. 132
Characterization of histamine secretion induced by anthracyclines in rat peritoneal mast cells. 132
Glucocorticoids in Pediatric Gastrointestinal Disorders 132
Role of ABC transporters in the BeWo trophoblast cell line. 132
Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response. 130
Adriamycin experimental cardiomyopathy in Swiss mice. Different effects of two calcium antagonistic drugs on ADM - induced cardiomyopathy. 130
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. 129
Impairment of motor coordination induced by Doxorubicin in mice. 129
Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. 126
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. 126
Effects of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on leukemic infiltration of brain and liver in mice bearing P388 leukemia. 126
Characterization of multidrug transporters in a normal renal tubular cell line resistant to doxorubicin. 125
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 125
Effect of polyethylene glycol 400 on adriamycin induced histamine release. 124
Effects of ICRF 159 on adriamycin-induced cardiomyopathy in rats. 124
Dimethyl sulfoxide inhibits histamine release induced by various chemicals. 124
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay 124
Adriamycin-induced histamine release from heart tissue in vitro. 123
Totale 17.477
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.878
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.993 0 0 286 977 387 681 672 610 500 306 359 215
2020/20213.773 331 243 318 439 374 409 326 272 213 395 144 309
2021/20222.595 124 158 123 243 56 225 186 104 299 277 160 640
2022/20233.860 372 559 271 571 369 647 32 318 425 57 162 77
2023/20242.382 128 170 107 139 249 197 444 460 39 66 225 158
2024/2025366 120 245 1 0 0 0 0 0 0 0 0 0
Totale 26.144